Psychedelic exposure in pregnancy: a scoping review to inform perinatal drug safety and clinical counseling.
Therapeutic advances in drug safety 2026 Ovie Martin Albert, Alexander Arthur
Psychedelic and psychedelic-adjacent substances, including 3,4-methylenedioxymethamphetamine (MDMA) and classic serotonergic hallucinogens, are undergoing renewed therapeutic investigation and remain in non-medical use. Inadvertent exposure during early, unrecognized pregnancy is clinically plausible, yet pregnancy-specific safety evidence is limited. To map and synthesize the extent,...